Sodium-glucose cotransporter-2 (SGLT-2) inhibitors used to treat type 2 diabetes might prevent dementia, providing greater benefits with longer treatment, suggests a large study from Korea published by The BMJ today.
SGLT-2 inhibitors show potential in preventing dementia in diabetes patients
- Post author:
- Post published:August 28, 2024
- Post category:uncategorized